Biotechnology News

Wed, 2014-05-14 13:01

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, Inc., a wholly-owned subsidiary of AstraZeneca plc (...

Wed, 2014-05-14 13:01

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that as a result of its “productive” discussion with officials of the U.S. Food and Drug Administration (FDA) last week, the Company plans to...

Wed, 2014-05-14 13:01

MADISON, Wis.--(BUSINESS WIRE)--Madison Vaccines Incorporated (MVI), a biopharmaceutical company focused on advancing innovative therapies for prostate cancer, announces the appointment of Michael Richman to its Board of Directors.

Wed, 2014-05-14 13:01

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--MyoKardia, Inc., a company pioneering the development of precision therapies for genetic heart disease, today announced the launch of the Sarcomeric Human Cardiomyopathy Registry (SHaRe), a multi-...

Wed, 2014-05-14 13:01

NEW YORK & HAMPTON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb and Celldex Therapeutics Announce Clinical Trial Collaboration to Evaluate the Combination of Investigational Immunotherapies Nivolumab and Varlilumab

Wed, 2014-05-14 13:01

WALTHAM, Mass.--(BUSINESS WIRE)--Proteon Therapeutics Announces Publication of Results from Phase 2 Study of PRT-201

Wed, 2014-05-14 13:01

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the quarter ended March 31, 2014. “The first quarter of 2014 was a transformative period for Retrophin,” said Martin Shkreli, Founder and Chief...

Wed, 2014-05-14 13:01

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck’s Investigational Anti-PD1 Antibody, MK-3475, Active in Three Different Tumor Types: New Data to be Presented at the 2014 ASCO Annual Meeting.

Wed, 2014-05-14 13:01

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced that it has selected HTX-011, a unique combination product utilizing its proprietary Biochronomer™ polymer-based...

Wed, 2014-05-14 13:01

HOLLISTON, Mass.--(BUSINESS WIRE)--David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), was interviewed by anchor Stuart Varney on the Fox Business News program Varney & Company on May 13.

Wed, 2014-05-14 13:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) has appointed Andrew Hindman as Chief Business Development Officer. “Business development is a key to Acorda’s growth strategy, and I am delighted that Andrew will lead our...

Wed, 2014-05-14 13:01

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals reports financial results for the first quarter of 2014.

Wed, 2014-05-14 13:01

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results for the quarter ended March 31, 2014. “...

Wed, 2014-05-14 13:01

NEWTON, Mass.--(BUSINESS WIRE)--Alcresta®, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the...

Wed, 2014-05-14 13:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ:VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at...

Wed, 2014-05-14 13:01

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing.

Wed, 2014-05-14 13:01

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. Reports Second Quarter 2014 Results

Wed, 2014-05-14 07:01

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Present at 2014 UBS Global Healthcare Conference

Wed, 2014-05-14 07:01

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced that its Board of Directors has decided to have separate roles of the Chairman of the Company and the Managing Director and CEO. It has appointed Satish...

Wed, 2014-05-14 07:01

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into a clinical study collaboration. The Phase I/II...

Wed, 2014-05-14 07:01

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data on nine approved and 18 investigational medicines will be presented during the 50th American Society...

Wed, 2014-05-14 07:01

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., Boston-based ophthalmic medical device and pharmaceutical company, welcomes Robert J. Palmisano, President & CEO of Wright Medical Group, Inc., to its Board of Directors.

Wed, 2014-05-14 (All day)

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company’s President and Chief Executive Officer, will provide a company overview at the UBS Global Health Care Conference on...

Tue, 2014-05-13 18:00

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas. John F. Milligan, PhD,...

Tue, 2014-05-13 18:00

CARLSBAD, Calif.--(BUSINESS WIRE)--Researchers can now simultaneously analyze samples for multiple genetic markers of interest in a single qPCR reaction with a set of new Life Technologies TaqMan multiplex reagents.

Tue, 2014-05-13 18:00

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high-performance cell transfection systems, is presenting a free webinar on May 14, 2014 with Cambridge Health Institute. The webinar, Accelerating Product Development:...

Tue, 2014-05-13 18:00

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH).

Tue, 2014-05-13 18:00

BOSTON--(BUSINESS WIRE)--Vertex will present at the UBS Healthcare Conference on Tuesday, May 20th at 11:00am ET.

Tue, 2014-05-13 18:00

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced operational and financial results for the quarter ending March 31, 2014. “2014 thus far has...

Tue, 2014-05-13 18:00

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports third quarter 2014 results; now plans to seek US approval of Medidur for Posterior Uveitis based on one phase III trial

Tue, 2014-05-13 18:00

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., a leading diagnostics and research services company offering metabolomics research platforms, has entered into a collaboration with GlaxoSmithKline (GSK) to provide metabolomic...

Tue, 2014-05-13 12:02

WASHINGTON--(BUSINESS WIRE)--DIA 2014 50th Annual Meeting to Explore Case Studies of Collaboration to Streamline Drug Development

Tue, 2014-05-13 12:02

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that a supply of Increlex® (mecasermin [rDNA origin] injection) will be available in the U.S. starting...

Tue, 2014-05-13 12:02

PHILADELPHIA--(BUSINESS WIRE)--RICHMAN CHEMICAL LAUNCHES CONSULTING SERVICES DIVISION
--Services Designed to Help Companies in the Life Sciences & Specialty Chemicals Commercialize Technology Cost Effectively & Rapidly

Tue, 2014-05-13 12:02

DOYLESTOWN, Pa.--(BUSINESS WIRE)--FlowMetric, Inc. has been selected for the 2014 Best of Doylestown Award in the Biotechnology Company category by the Doylestown Award Program.

Tue, 2014-05-13 12:02

BOSTON--(BUSINESS WIRE)--bigtincan, a leader in mobile content enablement, today announced that Waltham, Massachusetts-based biotechnology company, Thermo Fisher Scientific, has deployed bigtincan hub to more effectively deliver corporate content...

Tue, 2014-05-13 12:02

ARLINGTON, Va. & DEERFIELD, Ill.--(BUSINESS WIRE)--Stuart H. Altman, Ph.D., has been named the 2014 recipient of the William B. Graham Prize for Health Services Research. The Prize, funded by The Baxter International Foundation and managed by...

Tue, 2014-05-13 12:02

EXTON, Pa.--(BUSINESS WIRE)--Frontage Announces Expansion Plans for its Clinical Research Services; Names Eileen McAuley to Lead Efforts

Tue, 2014-05-13 12:02

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Asterias Biotherapeutics, Inc. today announced that Jane S. Lebkowski, PhD, President, Research & Development of Asterias, will present at the 17th Annual...

Tue, 2014-05-13 12:02

WALTHAM, Mass.--(BUSINESS WIRE)--Mascoma Corp, a leader in advanced bioconversion products, has named renowned microbiologist and yeast researcher Hans van Dijken Ph.D. to its Scientific Advisory Board.

Tue, 2014-05-13 12:02

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus Pharma announces completion of a $3.3M Series B round of financing. New data on Gemmus' flu therapy GP1681 will be presented at the International Conference on Antiviral Research.

Tue, 2014-05-13 12:02

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceuticals Industries Ltd., (NYSE:TEVA) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s supplemental new drug application (sNDA) for a lower dose QNASL...

Tue, 2014-05-13 12:02

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI reports second quarter fiscal 2014 financial results with recent key corporate and clinical developments.

Tue, 2014-05-13 12:02

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company will be presenting at the 2014 Global Healthcare Conference,...

Tue, 2014-05-13 12:02

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today positive top-line results from its ongoing Phase 1 trial of ALN-AT3, a subcutaneously administered RNAi...

Tue, 2014-05-13 12:02

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. reaches the enrollment target in the Phase IIb 'Abili-T' clinical trial of Tcelna, a personalized immunotherapy for Secondary Progressive Multiple Sclerosis.